HEALTHTHE HINDU NATIONAL
Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR
India's first dengue vaccine is nearing completion of its third phase clinical trials, according to ICMR. The country currently has no antiviral treatment or licensed vaccine for dengue and ranks among the top 30 nations with the highest incidence of the disease.
Related Signal
Adjacent reporting
- Deaths in Brazil raise concerns about India’s dengue vaccine, DengiAll
- Brazil suspends its dengue vaccine as a precaution after two deaths
- Rwanda: €15m Vaccine Clinical Trial On Mosquito-Borne Viral Disease Launched
- AI-designed 'universal vaccine' passes first human clinical trial, could prevent future pandemics
- Australia wants to become the first country to eliminate a cancer - can it?
- STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more